151. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells
- Author
-
Sandra Shahab, Hadassah Shinar, Peter Eberle, Gadi Turgeman, Gerhard Gross, Keren Keinan-Adamsky, Andreas Winkel, Dan Gazit, Gil Navon, Gadi Pelled, Yoram Zilberman, and Andrea Hoffmann
- Subjects
Transcriptional Activation ,Pathology ,medicine.medical_specialty ,Cellular differentiation ,Clinical uses of mesenchymal stem cells ,Bone Morphogenetic Protein 2 ,Smad Proteins ,Biology ,Bone morphogenetic protein ,Transfection ,Bone morphogenetic protein 2 ,Models, Biological ,Achilles Tendon ,Tendons ,Mice ,Rats, Nude ,Transforming Growth Factor beta ,medicine ,Humans ,Animals ,Microscopy, Phase-Contrast ,Cells, Cultured ,Cell Proliferation ,Mice, Inbred C3H ,Bone Development ,Tissue Engineering ,Histocytochemistry ,Regeneration (biology) ,Stem Cells ,Mesenchymal stem cell ,Cell Differentiation ,Mesenchymal Stem Cells ,General Medicine ,musculoskeletal system ,Recombinant Proteins ,Cell biology ,Protein Structure, Tertiary ,Rats ,Smad8 Protein ,Bone Morphogenetic Proteins ,Commentary ,Female ,Stem cell ,Biomarkers ,Adult stem cell ,Research Article ,Signal Transduction - Abstract
Tissue regeneration requires the recruitment of adult stem cells and their differentiation into mature committed cells. In this study we describe what we believe to be a novel approach for tendon regeneration based on a specific signalling molecule, Smad8, which mediates the differentiation of mesenchymal stem cells (MSCs) into tendon-like cells. A biologically active Smad8 variant was transfected into an MSC line that coexpressed the osteogenic gene bone morphogenetic protein 2 (BMP2). The engineered cells demonstrated the morphological characteristics and gene expression profile of tendon cells both in vitro and in vivo. In addition, following implantation in an Achilles tendon partial defect, the engineered cells were capable of inducing tendon regeneration demonstrated by double quantum filtered MRI. The results indicate what we believe to be a novel mechanism in which Smad8 inhibits the osteogenic pathway in MSCs known to be induced by BMP2 while promoting tendon differentiation. These findings may have considerable importance for the therapeutic replacement of tendons or ligaments and for engineering other tissues in which BMP plays a pivotal developmental role.
- Published
- 2004